SUMATRIPTAN — 6 mg/0.5 mL, Injection, 5 × 0.5 mL vial in 1 carton

SUMATRIPTAN — 6 mg/0.5 mL, Injection, 5 × 0.5 mL vial in 1 carton

SUMATRIPTAN is a injection for subcutaneous use. Sumatriptan Injection, USP is indicated in adults for (1) the acute treatment of migraine, with or without aura, and (2) the acute treatment of cluster headache. Supplied as 5 × 0.5 mL vial in 1 carton; NDC 0143-9638-05; manufacturer Hikma Pharmaceuticals USA Inc. Rx only. Store between 2° and 30°C (36° and 86°F). Protect from light.

• Active ingredient or product type: SUMATRIPTAN SUCCINATE
• Strength/concentration: 6 mg/0.5 mL
• Dosage form and route: Injection, Subcutaneous
• Exact package presentation: 5 × 0.5 mL vial in 1 carton
• NDC/item number: 0143-9638-05
• Manufacturer/labeler: Hikma Pharmaceuticals USA Inc.
• Storage/handling: Store between 2° and 30°C (36° and 86°F). Protect from light.
• Status: Rx only

Important safety information: Myocardial ischemia/infarction and Prinzmetal’s angina: Perform cardiac evaluation in patients with multiple cardiovascular risk factors.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.